Clovis Oncology Secures $65,635,000 New Financing

  • Feed Type
  • Date
    12/31/2009
  • Company Name
    Clovis Oncology
  • Mailing Address
    2525 28th Street Boulder, CO 80301
  • Company Description
    Clovis Oncology (NASDAQ: CLVS) is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets.
  • Website
    http://www.Clovisoncology.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $65,635,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Aberdare Ventures
  • Venture Investor
    Abingworth Management
  • Venture Investor
    Domain Associates
  • Venture Investor
    Frazier Healthcare Ventures
  • Venture Investor
    Frazier Technology Ventures
  • Venture Investor
    New Enterprise Associates
  • Venture Investor
    ProQuest Investments
  • Venture Investor
    Versant Ventures

By posting a comment, you agree to our terms and conditions.